|

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

RECRUITINGSponsored by University of Alberta
Actively Recruiting
SponsorUniversity of Alberta
Started2017-12-19
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations8 sites
View on ClinicalTrials.gov →

NCT03193151

Summary

INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* biopsy for clinical indications

Exclusion Criteria:

* no consent, pregnant women

Conditions2

Liver DiseaseLiver Dysfunction

Locations8 sites

University of California San Francisco, Transplant Research Unit
San Francisco, California, 94143
Northwestern Memorial Hospital
Chicago, Illinois, 60611
University of Maryland School of Medicine
Baltimore, Maryland, 21201
Henry Ford Transplant Institute
Detroit, Michigan, 48202
Dilip Moonka, MDDMOONKA1@hfhs.org
Vanderbilt University Medical Center, Vanderbilt Transplant Center
Nashville, Tennessee, 37232

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.